Risk adjusted net present value: What is the current valuation of F. Hoffmann-La Roche’s Basmisanil?

Basmisanil is a small molecule commercialized by F. Hoffmann-La Roche, with a leading Phase II program in Dup15q Syndrome.

Inovalon and MEDITECH Alliance Partner to Streamline Revenue Cycle Management

What You Should Know: – Inovalon, an innovator in cloud-based healthcare data solutions, announced a strategic partnership with the MEDITECH Alliance. – The strategic collaboration

June 28, 2024

Novo Nordisk’s move to discontinue an insulin leaves patients to ‘pick up the pieces’

A year ago, when Novo Nordisk announced it would cut the price of multiple insulin products by up to 75%, President Biden, lawmakers, and patient

April 24, 2024

Pharmalittle: We’re reading about a Roivant deal, limited access to medicines and more

Top of the morning to you and a fine one it is. Blue skies, cool breezes and plenty of chirping birds are enveloping the comfy

September 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.